Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption

Journal of Investigative Dermatology

Volumn 109, Issue 2, 1997, Pages 175-182

  Nishijima, Takafumi ^a,b   Tokura, Yoshiki ^a   Imokawa, Genji ^b   Seo, Naohiro ^a   Furukawa, Fukumi ^a   Takigawa, Masahiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAO CORPORATION   (Japan)

Author keywords

Acetone rubbing; Contact sensitivity; Langerhans cells; Tape stripping

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ACETONE; CD86 ANTIGEN; HAPTEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; LIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PICRYL CHLORIDE; TETRACHLORSALAN; TRINITROPHENYL; WATER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTACT SENSITIVITY; EPIDERMIS CELL; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; LANGERHANS CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PHOTOSENSITIVITY; PHYSICAL STRESS; PRIORITY JOURNAL; SKIN; SKIN PERMEABILITY; T LYMPHOCYTE;

EID: 0030748429     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12319282     Document Type: Article

References (51)

1. Aiba S, Katz SI: Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 145:2791-2796, 1990
2. Baliga P, Chavin KD, Qin L, Woodward J, Lin J, Linsley PS, Bromberg JS: CTLA4 Ig prolongs allograft survival while suppressing cell-mediated immunity. Transplantation 58:1082-1090, 1994
3. + dendritic epidermal cells in murine epidermis influences the intensity of contact hypersensitivity. J Invest Dermatol 89:495-499, 1987
4. Bos JD, Das PK, Kapsenberg ML: The skin immune system (SIS). In: Bos JD (ed.). Skin Immune System (SIS). CRC, Boca Raton, FL, 1990, pp 3-8
5. Chang CH, Furue M, Tamaki K: Selective regulation of ICAM-1 and major histocompatibility complex class I and IE molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur J Immunol 24:2889-2895, 1994
6. Elias PM, Feingold KR: Lipid-related barriers and gradients in the epidermis. Ann NY Acad Sci 548:4-13, 1988
7. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24:1-26, 1991
8. Enk AH, Angeloni VL, Udey MC, Katz SI: An essential role for Langerhans cell-derived IL-1 β in the initiation of primary immune responses in skin. J Immunol 150:3698-3704, 1993
9. Flynn GL: Mechanism of percutaneous absorption from physicochemical evidence. In: Bronaugh RL, Maibach HI (eds.). Percutaneous Absorption, 2nd ed. Marcel Dekker, New York, 1989, pp 27-51
10. Grubauer G, Elias PM, Feingold KR: Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 30:323-333, 1989a
11. Grubauer G, Feingold KR, Elias PM: The relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res 28:746-752, 1987
12. Grubauer G, Feingold KR, Harris RM, Elias PM: Lipid content and lipid type as determinants of the epidermal permeability barrier. Adv Lipid Res 30:89-96, 1989b
13. Heufler C, Koch F, Schuler G: Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700-705, 1988
14. Holleran WM, Feingold KR, Mao-Quiang M, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 32:1151-1158, 1991
15. Ibrahim MAA, Benjamin MC, Katz DR: The injured cell: the role of the dendritic cell system as a sentinel receptor pathway. Immunol Today 16:181-186, 1995
16. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dertnatol 96:523-526, 1991
17. Inaba K, Witmer-Pack M, Inaba M, Hathcock KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S, Muramatsu S, Hodes RJ, Steinman RM: The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 180:1849-1860, 1994
18. Janeway CA Jr, Bottomly K: Signals and signs for lymphocyte responses. Cell 76:275-285, 1994
19. Julius MH, Simpson E, Herzenberg LA: A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 3:645-649, 1973
20. Kawamura T, Furue M: Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur J Immunol 25:1913-1917, 1995
21. Koch F, Heufler C, Kämpgen E, Schneeweiss D, Böck G, Schuler G: Tumor necrosis factor a maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J Exp Med 171:159-171, 1990
22. Kupper TS: Immune and inflammatory processes in cutaneous tissues. J Clin Invest 86:1783-1789, 1990
23. Kupper TS, Ballard DW, Chua AD, McGuire JS, Flood PM, Horowitz MC, Langdon R, Lightfoot L, Gubler U: Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1α and β mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. J Exp Med 164:2095-2100, 1986
24. Lammintansta K, Maibach HI: Exogenous and endogenous factors in skin irritation. Int J Dermatol 27:213-222, 1988
25. Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, Pearson TC: Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 152:5208-5219, 1994
26. Lee MG, Borkowski TA, Udey MC: Regulation of expression of B7 by murine Langerhans cells: a direct relationship between B7 mRNA levels and the level of surface expression of B7 by Langerhans cells. J Invest Dermatol 101:883-886, 1993
27. Luger TA, Stadler BM, Luger BM, Mathieson BJ, Mage M, Schmidt JA, Oppenheim JJ: Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1. J Immunol 128:2147-2152, 1982
28. Menon GK, Feingold KR, Elias PM: The lamellar body secretory response to barrier disruption. J Invest Dermatol 98:279-289, 1992
29. Menon GK, Feingold KR, Moser AH, Brown BE, Elias PM: De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J Lipid Res 26:418-427, 1985
30. Nickoloff BJ, Naidu Y: Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-546, 1994
31. Ottey KA, Wood LC, Grunfeld C, Elias PM, Feingold KR: Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. J Invest Dermatol 104:401-404, 1995
32. Ozawa H, Nakagawa S, Tagami H, Aiba S: Interleukin-1β and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 106:441-445, 1996
33. Polla L, Margolis R, Goulston C, Parrish JA, Granstein RD: Enhancement of the elicitation phase of the murine contact hypersensitivity response by prior exposure to local ultraviolet radiation. J Invest Dermatol 86:13-17, 1986
34. Proksch E, Feingold KR, Mao-Quiang M, Elias PM: Barrier function regulates epidermal DNA synthesis. J Clin Invest 87:1668-1673, 1991
35. Puré E, Inaba K, Crowley MT, Tardelli L, Witmer-Pack MD, Ruberti G, Fathman G, Steinman RM: Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J Exp Med 172:1459-1469, 1990
36. Sauder DN, Carter CS, Katz SI, Oppenheim JJ: Epidermal cell production of thymocyte activating factor (ETAF). J Invest Dermatol 79:34-39, 1982
37. Scheynius A, Camp RL, Puré E: Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J Immunol 150:655-663, 1993
38. Scheynius A, Camp RL, Puré E: Unresponsiveness to 2,4-dinitro-1-fluoro-benzene after treatment with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1 during sensitization. J Immunol 156:1804-1809, 1996
39. Schwarz RH: Costimulation of T lymphocytes; The role of CD28, CTLA-4, and B-7/BB1 in interleukin 2 production and immunotherapy. Cell 71:1065-1068, 1992
40. Shaw JE, Provo M, Gale R, Yum SI: Percutaneous absorption. In: Goldsmith LA (ed.). Physiology, Biochemistry, and Molecular Biology of the Skin. 2nd ed. Oxford University Press, New York, 1991, pp 1447-1479
41. Shimada S, Caughman SW, Sharrow SD, Stephany D, Katz SI: Enhanced antigen-presenting capacity of cultured Langerhans cells is associated with markedly increased expression of Ia antigen. J Immunol 139:2551-2555, 1987
42. Streilein JW: Skin-associated lymphoid tissue (SALT); origins and functions. J Invest Dermatol 80:12s-16s, 1983
43. Streilein JW, Lonsberry LW, Bergstresser PR: Depletion of epidermal Langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med 155:863-871, 1982
44. Symington FW, Brady W, Linsley PS: Expression and function of B7 on human epidermal Langerhans cells. J Immunol 150:1286-1295, 1993
45. Tokura Y, Yagi H, Satoh T, Takigawa M: Inhibitory effect of melanin pigment on sensitization and elicitation of murine contact photosensitivity: mechanism of low responsiveness in C57BL/10 background mice. J Invest Dermatol 101:673-678, 1993
46. Tokura Y, Yagi J, O'Malley M, Lewis JM, Takigawa M, Edelson RL, Tigelaar RE: Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 102:31-38, 1994
47. Udey MC, Peck RD, Pentland AP, Schreiner GF, Lefkowith JB: Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells. J Invest Dermatol 96:950-958, 1991
48. Witmer-Pack MD, Oliver W, Valinsky J, Schuler G, Steinman RM: Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166:1484-1498, 1987
49. Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR: Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106:397-403, 1996
50. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld C, Feingold KR: Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 103:834-838, 1994
51. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487, 1992